Major superficial radiation therapy system market players are leveraging patient and healthcare professional bias towards minimally invasive therapies for skin cancer, to boost revenues in the post-pandemic era.

The global superficial radiation therapy system market is expected to reach a valuation of approximately US$ 57.3 Mn between 2020 and 2030. The global coronavirus outbreak is anticipated to have a moderate impact on the industry throughout the pandemic crisis. While the essential nature of basal and squamous cell cancer treatments will support demand. Strict procedures to screen covid-19 patients prior to superficial radiation therapy treatments holds back application rates during this period.

“Growing efforts for the testing and approval of superficial radiation therapy by government bodies are key factors contributing to growth prospects. Further, growing consumer bias against invasive treatment options and research investments for oncology will help long-term growth of the industry,” says the FMI study.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5279

Superficial Radiation Therapy System Market – Key Takeaways

• Basal cell carcinoma applications account for significant revenue share, owing to high incidence rates particularly among fair-skinned populations.
• Targeted therapy systems are witnessing major growth, supported by minimal risks of side effects.
• North America is a prominent market for superficial radiation therapy systems, owing to higher numbers of treatment centers, and clinical trials in the region.

Superficial Radiation Therapy System Market – Key Driving Factors

• Major investments towards the development of non-invasive skin cancer treatments, and portable devices are key to market developments.
• Rising numbers of awareness programs run by governments on skin cancer and treatment options are bolstering growth prospects.

Superficial Radiation Therapy System Market – Key Constraints

• Debate about the efficacy of superficial radiation therapy in healthcare circles is holding back adoption.
• Prohibitive costs of operating superficial radiation therapy systems restrict market growth.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-5279

The Anticipated Impact of Coronavirus

The superficial radiation therapy systems market has been moderately limited in applications during the coronavirus pandemic. Lockdown restrictions and social distancing guidelines have resulted in delayed appointments for superficial radiation therapy treatments. Disinfection requirements and strict screening for covid-19 cases, restricts access to patients and hurts operation rates limiting demand for superficial radiation therapy systems in the short term. Recovery is highly dependent on the timeline to bring the pandemic under control.

Competition Landscape

Major manufacturers in the superficial radiation therapy system market include but are not limited to Nordion Inc., Sensus Healthcare, Xstrahl Ltd., SkinCure, IsoRay Inc., Mevion Medical Systems, Mitsubishi Electric Corp., Varian Medical Systems, Electa AB, Ion Beam Applications, and RaySearch Laboratories.

Superficial radiation therapy system manufacturers have been investing in strategic collaborations and acquisitions for product innovation and manufacturing capability enhancements.

For instance, Sensus Healthcare has announced the acquisition of Aesthetic Laser Partners and Aesthetic Mobile Laser Services for dermatology capabilities including superficial radiation therapy systems. IntraOp Medical Corp. has entered into a partnership with the Lausanne University Hospital for clinical trials of FLASH radiotherapy which includes superficial radiation therapy functionality. Also, Stratpharma Inc. has joined hands with Sensus Healthcare for development of topical medical products including superficial radiation therapy systems.